Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

M-estimation in cross-over trials

E M Chi1

  • 1Hoechst-Roussel Pharmaceuticals Inc., Somerville, New Jersey 08876.

Biometrics
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

A new robust statistical method, combined M-estimation, effectively analyzes crossover data even with outliers. This approach outperforms traditional methods, offering more reliable treatment effect estimates in complex datasets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of variance for repeated measures. Data: a generalized estimating equations approach.

Statistics in medicine·1992
Same author

Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1992
Same author

Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.

Arteriosclerosis and thrombosis : a journal of vascular biology·1991
Same author

Recovery of inter-block information in cross-over trials.

Statistics in medicine·1991
Same author

NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations.

European journal of pharmacology·1991
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Area of Science:

  • Biostatistics
  • Statistical Modeling
  • Clinical Trial Analysis

Background:

  • Crossover study designs are common in clinical research.
  • Analyzing crossover data can be challenging due to potential outliers.
  • Existing methods may lack robustness in the presence of within- and between-subject variability.

Purpose of the Study:

  • To introduce a robust statistical procedure for analyzing crossover data.
  • To evaluate the performance of the proposed method in the presence of outliers.
  • To compare the proposed method with existing techniques for estimating treatment effects.

Main Methods:

  • Development of a combined M-estimation procedure.
  • Simulation studies to assess mean squared error properties.

Related Experiment Videos

  • Comparison with generalized least squares estimates.

    • Main Results:

    • The combined M-estimation procedure demonstrates robustness to within- and between-subject outliers.
    • Mean squared error properties of M-estimates are favorable compared to generalized least squares.
    • The proposed method provides superior estimates for direct and carryover treatment effects.

    Conclusions:

    • Combined M-estimation is a robust and effective method for analyzing crossover data with outliers.
    • This procedure offers improved accuracy for treatment effect estimation in challenging datasets.
    • The findings support the use of combined M-estimation in biostatistical and clinical trial analysis.